MYRIAD GENETICS, INC. Increase (Decrease) in Other Noncurrent Liabilities
MYRIAD GENETICS, INC. (MYGN) reported Increase (Decrease) in Other Noncurrent Liabilities of $4.30 million for the 12-month period ending 2020-06-30, per its 10-KT filed 2021-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2021-03-16
- MYRIAD GENETICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $4.30M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|
| 2020-06-30 | $4.30M 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |